Nowadays nanoparticles have widespread application in various industriesbecause of their special and unique features, there are many studies in sideeffects of nanomaterial. This study done by 40 white female mice withevery other day intraperitoneally injection of low and high doses of both ofZnO kg of body weight) and FeOnanoparticles (5 and 40 mg/kg). After a 15 days period, the mice weresacrificed and blood samples were collected for hormone analysis, andtissue samples for morphometric studies.Statistical Analysis shows significant differences in LH, Estrogen,Progesterone hormone levels between groups, while there are insignificantdifferences in Follicle stimulating hormone (FSH) level between thegroups compared with its level in

Background: Nanotechnology has emerged as a pivotal domain in material science research with extensive applications across various sectors including biotechnology and medicine. Nanoparticles offer unique properties facilitating advancements in nanobiotechnology, particularly in nanomedicine, to combat bacterial infections and antibiotic resistance. This study aimed to determine the application of nanoparticles, specifically nano-TiO2, in treating plasmid-mediated antibiotic resistance in both Gram-negative and Gram-positive bacteria. Method: We evaluated antibiotic and nanomaterial sensitivity through disc diffusion and broth microdilution assays. Plasmid curing experiments were conducted using varying concentrations of nano-TiO2 an

     Psoriasis is a common, persistent papulosquamous skin illness that affects people of all ages and has a high societal and personal burden. It is associated with various serious medical conditions like depression, psoriatic arthritis, and cardiometabolic syndrome. Interleukin-36a (IL-36a) is a key molecule in inflammation, coordinating the activation of critical pro-inflammatory cytokines and immune cells. The current study involved 84 Iraqi psoriatic patients (PoS) and 67 healthy controls. Real-time PCR and sequencing techniques were used to evaluate the gene expression and polymorphism of two SNPs (rs2305152 A/C and rs895497 G/A) of the IL-36a gene. The findings revealed that the IL-36a gene was up-regulated in psoriatic patien